Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.750
-0.220 (-5.54%)
At close: Feb 21, 2025, 4:00 PM
3.760
+0.010 (0.27%)
After-hours: Feb 21, 2025, 5:59 PM EST
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $559.06 million as of February 21, 2025. Its market cap has increased by 53.31% in one year.
Market Cap
559.06M
Enterprise Value
760.62M
1-Year Change
53.31%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $559.06M, an increase of 89.01%. That is a compound annual growth rate of 20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 559.06M | 10.62% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |